Navigation Links
Dehaier Medical Announces Record Second Quarter 2011 Financial Results

BEIJING, Aug. 15, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the second quarter ended June 30, 2011.


Second Quarter 2011 Financial Highlights

  • Revenue of $7.7 million, up 60% over the $4.8 million reported in the second quarter of 2010.
  • Gross profit was $2.8 million, or 36.8% of revenue, compared with $1.9 million, or 39.7% of revenue in the second quarter of 2010.
  • Operating income and operating margin were $1.9 million and 25.0%, respectively, compared with $1.4 million and 28.1%, respectively, in the second quarter of 2010.
  • Net income attributable to the Company was $1.7 million, or $0.39 per diluted share, which compares to net income of $1.1 million, or $0.27 per diluted share in the second quarter of 2010.
  • As of June 30, 2011 cash and cash equivalents were $3.0 million and working capital totaled $25.1 million.

  • Financial Highlights for the Six Months Ended June 30, 2011

  • Revenue of $10.7 million, an increase of 42.7% over the $7.5 million reported in the first half of 2010.
  • Gross profit was $3.8 million, or 36.0% of revenue, compared with $2.9 million, or 38.7% of revenue in the same period in 2010.
  • Operating income and operating margin were $2.2 million and 20.8%, respectively, compared with $2.0 and 26.8%, respectively, in the first half of 2010.
  • Net income attributable to the Company was $1.9 million, or $0.43 per diluted share, based on weighted average shares outstanding of 4.5 million, compared with $1.7 million, or $0.46 per diluted share, based on weighted avether receivables2,810(1,266,137)   Decrease (Increase) in inventories96,299(837,443)   Increase in tax receivable(911,942)(563,918)   Increase (Decrease) in accounts payable1,153,882(77,095)   Decrease in advances from customers(116,220)(81,647)   Increase in accrued expenses and other current liabilities9,502159,880   Increase in tax payable2,022,8121,118,579Net cash used in operating activities(3,356,331)(4,622,473)Cash flows from investing activitiesCapital expenditures and other additions(62,302)(94,397)Advances to related parties(2,358)(3,861)Net cash used in investing activities(64,660)(98,258)Cash flows from financing activitiesProceeds from bank loan1,542,680-Repayment of bank loan(1,533,604)-Net proceeds from issuance of common shares-9,944,207Net cash provided by financing activities9,0769,944,207Effect of exchange rate fluctuations on cash and cash equivalents 496,552164,812Net (decrease) increase in cash and cash equivalents(2,915,363)5,388,288Cash and cash equivalents at beginning of period5,923,3861,151,721Cash and cash equivalents at end of period3,008,0236,540,009Supplemental cash flow informationIncome tax paid13,26024,604Interest paid26,99326,728The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. rage shares outstanding of 3.6 million in the first six months of 2010.

  • Second Quarter 2011 and Recent Business Highlights

  • Launched home oxygen therapy service program in Beijing through a strategic cooperation agreement with leading medical oxygen provider, Taiyo Nippon Sanso Shenwei Medical Gas ("Taiyo-Shanghai") and Beijing Orient Medical Gas ("Beijing Orient"), and opened the Company's first oxygen filling facility and first service center in the Haidian District, Beijing, China.
  • Signed exclusive agreement with distributor in Taiwan to distribute Dehaier Continuous Positive Airway Pressure ("CPAP") devices, marking the Company's first distribution authorization outside of the PRC.
  • Strengthened intellectual property portfolio with grant by PRC State Intellectual Property Office ("SIPO") for three design patents related to Dehaier's sleep diagnostic products, CPAP products and medical-grade air compressors.
  • Won a bid and signed a medical equipment supply agreement valued at approximately $1.3 million with Beijing Hospital 301, one of the largest and most prominent medical facilities in China.
  • Signed a cooperation agreement with Beijing Kanglian Medicines Co., Ltd. to develop, operate and implement a new rural healthcare construction project in Hunan and Anhui provinces, which is supported by China Development Bank Corporation.
  • Appointed Dr. Xiaoqing Wang as the Company's Chief Technology Officer. Dr. Wang brings more than 20 years of biomedical engineering experience to Dehaier, and will be focused on leading the development of second-generation oxygen concentrators and second-generation PAP ventilators, such as CPAP, BiPAP, etc.

  • "Increased acceptance of Dehaier products by hospitals and other healthcare facilities, as well as growth in government projects were the primary catalysts behind our strong top and bottom line performance in the second quarter," said Mr. Ping Chen, CEO of Dehaier. "We are building our brand domestically as both a distributor and a trusted partner, and making progress toward the expansion of our homecare business beyond China. Our strong intellectual property portfolio continues to distinguish Dehaier in the marketplace, and we believe the addition of Dr. Wang will contribute tremendously to our R&D capabilities as well as our product development.  Dehaier remains committed to investing in ongoing innovation and enriching our product portfolio as we strive to provide customers with an all-in-one solution to meet their individual needs. We believe such initiatives will drive future financial gains and help to secure our growth over the longer term."

    Mr. Chen added "Our cooperation agreement with Taiyo-Shanghai and Beijing Orient for home oxygen therapy service was a milestone for our homecare business, as were the opening of our first oxygen filling facility and first service center in July. Since launching this service in late April, we have received favorable reviews and gathered valuable customer feedback that is yielding tangible benefits that support our ongoing development and marketing efforts. In addition, we are developing a customer database that will provide us with cross-selling opportunities for our other homecare products.  We are pleased with the early results of this cooperation, and believe that this segment of our business can achieve tremendous growth once legislation is passed in Beijing to provide insurance reimbursement eligibility for home oxygen therapy services. Our plan to expand this business into other cities in China remains on track, enabling Dehaier to benefit from its first-mover advantage and capture sizeable share within this emerging market.

    "We believe there are significant opportunities to further penetrate the market and are confident that our innovative products, diversified marketing channels and network, growing customer database, and geographic expansion efforts collectively position Dehaier to accelerate growth among China's developing healthcare industry," concluded Mr. Chen.

    Second Quarter 2011 Financial ResultsRevenuesRevenues for the three months ended June 30, 2011 were $7.7 million, compared with $4.8 million for the three months ended June 30, 2010, an increase of $2.9 million, or 60%. The increase in revenue was attributable to sales growth from the Company's medical devices and homecare solutions businesses.

  • Sales of self-branded and third party medical devices, including technical service products, increased 38% to $5.9 million, or 77% of total revenue, compared with $4.3 million, or 89% of revenue in the same period a year ago. The sales increase in the medical devices segment was primarily related to the expansion of the Company's portfolio of third-party-branded products, an increase in follow-on orders from key customers, and Dehaier's extensive marketing network.
  • Homecare products revenue more than tripled to $1.8 million, or 23% of total revenue, compared to $534,000, or 11% of revenue in the second quarter of 2010. The increase in sales from homecare products was primarily attributable to additional market penetration and expansion of Dehaier's homecare products.

  • Gross ProfitGross profit for the three months ended June 30, 2011 increased to $2.8 million, compared with $1.9 million in the three months ended June 30, 2010. As a percentage of revenue, the Company's gross margin was 36.8% for the three months ended June 30, 2011, compared with 39.7% for the same period in 2010. This fluctuation in gross margin is normal for the Company because we adjust our products portfolio according to customer requirements and market conditions, etc.

    Income from OperationsOperating income for the three months ended June 30, 2011 totaled $1.9 million, compared with $1.4 million for the three months ended June 30, 2010.

    Operating expenses for the quarter totaled $967,000, an increase of 58%, compared with $612,000 for the same period a year ago. In addition to the business expansion, the increase in operating expenses was attributable to a $0.2 million increase in G&A expenses associated with increased R&D related to oxygen and respiratory products, and, expenses associated with being a publicly traded company, including costs of maintaining and enhancing our internal controls, and a $0.1 million increase in selling expenses for marketing and network building.

    Net IncomeNet income attributable to the Company for the three months ended June 30, 2011 was $1.7 million, compared with $1.1 million for the three months ended June 30, 2010. The increase in net income was primarily due to robust top line growth. Earnings per diluted share were $0.39, based on 4.5 million shares outstanding for the quarter, compared with diluted EPS of $0.27, based on 4.3 million shares outstanding for the second quarter of 2010.

    Liquidity and Capital ResourcesAs of June 30, 2011, Dehaier had $3.0 million in cash and cash equivalents, compared with $5.9 million as of December 31, 2010. The decrease was primarily to the result of an increase in prepayments due to more distribution agreements requiring prepayment for products. Current assets totaled $39.0 million, with working capital of $25.1 million and total shareholders' equity of $27.0 million at June 30, 2011, respectively.

    Conference Call and WebcastManagement will host a conference call to discuss these financial results on Monday, August 15, 2011 at 8:00 a.m. EDT.

    To participate in the call please dial (877) 941-8416 in the U.S. and Canada, or (480) 629-9808 for international calls, approximately 10 minutes prior to the scheduled start time. Interested parties can also listen via a live Internet webcast, which can be found on the Company's website at

    A replay of the call will be available approximately 2 hours after the conclusion of the live call, through August 29, 2011. The replay can be accessed by dialing (800) 406-7325 in the U.S. and Canada, or (303) 590-3030 internationally and entering the passcode: 4462671. In addition, a recording of the call will be available via the company's website at for one year.

    About Dehaier Medical Systems Ltd.Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on six patents and five software copyrights; additionally, we have two pending patents and six pending software copyrights, and proprietary technology. More information may be found at

    Forward-looking StatementsThis news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.Contact UsIn the US:

    Dehaier Medical Systems LimitedThe Piacente Group, Inc.

    Rita LiuInvestor Relations

    CFOBrandi Floberg or Lee Roth

    +86-10-8844-5026+1-212-481-2050 In China:The Piacente Group, Inc. Investor RelationsWendy DEHAIERMEDICAL SYSTEMS LIMITED AND AFFILIATECONDENSED CONSOLIDATED BALANCE SHEETS(UNAUDITED)June 30,December 31, 20112010US$US$ASSETSCURRENT ASSETS:Cash and cash equivalents

    3,008,0235,923,386Accounts receivable-less allowance for doubtful accounts of $89,437 and $87,555 at June 30, 2011 and December 31, 2010, respectively

    12,563,3469,112,077Other receivables

    3,161,6133,164,423Prepayment and other current assets

    9,541,5845,300,825Inventories, net

    6,278,0646,374,363Tax receivable

    4,430,8613,518,919Total Current Assets 38,983,49133,393,993Property and equipment, net

    3,404,6393,488,947Total Assets 42,388,13036,882,940LIABILITIES AND EQUITY CURRENT LIABILITIES:Short-term borrowings

    1,547,1701,514,620Accounts payable  

    1,183,20029,318Advances from customers

    152,969269,189Accrued expenses and other current liabilities

    340,103330,601Tax payable

    10,350,5208,327,708Warranty obligation

    307,943301,464Due to officer

    -2,358Total Current Liabilities 13,881,90510,775,258OTHER LIABILITIESWarrants liability

    168,242318,109Total Liabilities14,050,14711,093,367Commitments and ContingencyEquityCommon shares, $0.002731 par value, 18,307,038 shares authorized, 4,510,000 and 4,500,000 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively

    12,31712,290Additional paid in capital

    13,196,35713,137,085Retained earnings

    11,781,9439,838,452Accumulated other comprehensive income

    1,985,8301,474,455Total Dehaier Medical Systems Limited shareholders' equity 26,976,44724,462,282Non-controlling interest

    1,361,5361,327,291Total equity 28,337,98325,789,573Total liabilities and equity 42,388,13036,882,940The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.DEHAIERMEDICAL SYSTEMS LIMITED AND AFFILIATECONDENSED CONSOLIDATED STATEMENTS OF INCOME ANDCOMPREHENSIVE INCOME(UNAUDITED)For the six months ended
    June 30, For the three months ended
    June 30, 2011 2010 2011 2010US$US$US$US$Revenue 10,665,4907,471,9517,712,7844,830,862Costs of revenue (6,826,494)(4,577,795)(4,871,247)(2,911,077)Gross profit 3,838,9962,894,1562,841,5371,919,785Service income

    156,428181,50671,59588,439Service expenses

    (61,372)(68,346)(20,675)(40,325)General and administrative expense

    (1,016,167)(520,409)(512,641)(297,024)Selling expense

    (694,493)(482,810)(454,792)(314,959)Operating Income 2,223,3922,004,0971,925,0241,355,916Financial expenses (including interest expense of $26,993, $26,728, $10,816 and $7,900 for the six and three months ended June 30, 2011 and 2010, respectively)

    (27,472)(54,686)(11,859)(35,360)Change in fair value of warrants liability

    149,86718,394140,34118,394Income before provision for income taxes and non-controlling interest  2,345,7871,967,8052,053,5061,338,950Provision for income tax

    (396,642)(298,180)(314,105)(203,297)Net income 1,949,1451,669,6251,739,4011,135,653Non-Controlling interest in (income) loss

    (5,654)(9,991)(1,324)3,770Net income attributable to Dehaier Medical Systems Limited 1,943,4911,659,6341,738,0771,139,423Net Income1,949,1451,669,6251,739,4011,135,653Other comprehensive incomeForeign currency translation adjustments

    511,375127,158324,095125,522Comprehensive Income2,460,5201,796,7832,063,4961,261,175Comprehensive income attributable to the non-controlling interest

    (28,591)(8,546)(17,685)(8,335)Comprehensive income attributable to Dehaier Medical Systems Limited2,431,9291,788,2372,045,8111,252,840Earnings per share-Basic


    0.430.460.390.27Weighted average number of common shares used in computation-Basic


    4,506,3543,632,5004,510,0004,265,000The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. DEHAIERMEDICAL SYSTEMS LIMITED AND AFFILIATECONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(UNAUDITED)For the six months ended
    June 30,20112010US$US$Cash flows from operating activitiesNet income1,949,1451,669,625Adjustments to reconcile net income to net cash used in operating activitiesStock-based compensation expense59,300-Depreciation and amortization219,976172,314Change in fair value of warrants liability(149,867)(18,394)Recovery of doubtful accounts-(25,680)Recovery of inventory obsolescence-(1,922)Changes in assets and liabilities: Increase in accounts receivable(3,451,269)(1,950,032)Increase in prepayments and other current assets(4,240,759)(2,920,603)   Decrease (Increase) in o

    SOURCE Dehaier Medical Systems Ltd.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Dehaier Medical to Report Second Quarter 2011 Financial Results on August 15
    2. Dehaier Opens First Oxygen Filling Facility and First Service Center for Home Oxygen Therapy Service in Beijing
    3. Dehaier Medical Systems Names Dr. Xiaoqing Wang New Chief Technology Officer
    4. Dehaier Strengthens Intellectual Property Portfolio
    5. Dehaier Awarded $1.32 Million Procurement Contract to Supply Medical Devices to Hospital 301 in Beijing
    6. Dehaier Medical Announces First Quarter 2011 Financial Results
    7. Dehaier Medical to Report First Quarter 2011 Financial Results on May 4
    8. Dehaier Medical Chairman and CEO Issues Letter to Shareholders
    9. Dehaier Medical Systems Signs New Distribution Agreement to Distribute eVent Medical Ventilators
    10. Dehaier Medical Announces Fourth Quarter and Full-Year 2010 Financial Results
    11. Dehaier Medical to Report Fourth Quarter and Full-Year 2010 Financial Results on March 7
    Post Your Comments:
    (Date:10/9/2015)... , Oct. 9, 2015  Hi-Tech Pharmaceuticals ("Hi-Tech"), ... Contract Manufacturing, and iForce Nutrition ("iForce"), one of the ... United States , today announced that they ... Hi-Tech has agreed to acquire iForce. The transaction ... expand its distribution through iForce,s strong distribution network. ...
    (Date:10/9/2015)... Eli Lilly and Company (NYSE: LLY ) ... 50 new jobs to its research and development presence at ... New York . --> ... include a translational immuno-oncology hub and a Lilly "portal," which ... to cutting-edge drug discovery capabilities, including chemistry and lead optimization ...
    (Date:10/9/2015)... 9, 2015 Ansun BioPharma announced a presentation ... America ) regarding the compassionate use of DAS181 under ... respirator who was co-infected with influenza and parainfluenza (Abstract ... therapy, O 2 requirement was reduced and the ... to go off the respirator on day 5. Between ...
    Breaking Medicine Technology:
    ... MINNEAPOLIS, Jan. 19, 2012 Zyga Technology, Inc. announced ... the company and will serve as Vice President of ... (Logo: ) Joe ... Medical Device Industry.  He began his career at Codman ...
    ... Berkery Noyes, an independent middle market investment bank, today ... trend report for the Pharma & Healthcare ... report analyzes the sector for 2011 and compares it ... includes information and technology companies servicing pharmaceutical, healthcare payer, ...
    Cached Medicine Technology:
    (Date:10/9/2015)... ... October 09, 2015 , ... A new health tool that helps ... now available online ( ) – just in time for the cold and ... in October. However, for many in the U.S., the real start of cold/flu season ...
    (Date:10/9/2015)... ... 2015 , ... Head Over Heels Athletic Arts gymnast, Madelyn Williams, will attend ... Ranch in Huntsville, Texas on October 17-21. , "It's very exciting to be ... and executive director, said. “It's a stepping stone into the U.S. elite system where ...
    (Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... ... serving New Orleans and the surrounding communities, is initiating a combined charity effort ... care for unwanted animals in southern Louisiana. , Animal Rescue New Orleans ...
    (Date:10/9/2015)... TN (PRWEB) , ... October 09, 2015 , ... Santa ... announce their partnership as MD Anderson prepares to go-live on the Epic platform in ... planned for early 2016. Santa Rosa will execute the contract by supporting Scheduling Appointment ...
    (Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... Smanos was ... and coolest technology products available to consumers. Scott Steinberg, a technology expert and special ... is perfect for any home or dorm. , In this day and age it’s ...
    Breaking Medicine News(10 mins):
    ... unattractive can be a stronger motivation for keeping people going ... study says. , Researchers at the University of Bath, ... to imagine a physically unattractive version of themselves they feared ... to either imagine a scenario in which they dramatically failed ...
    ... LA JOLLA, Calif., Nov. 27 TorreyPines,Therapeutics, Inc. ... Michael Murphy,Chief Medical Officer of TorreyPines, will present ... in New York on Tuesday, December 4th,at 3:00 ... presentation will be available live. You can,access the ...
    ... to Store Shelves, CINCINNATI, Nov. 27 Procter ... new to store shelves, will now,be sold in St. ... -- a source of healthy bacteria that builds and ... digestive upsets, such as,constipation, diarrhea, abdominal discomfort, urgency, gas ...
    ... 27 Datasci, LLC and etrials Worldwide,Inc. announced ... settled.,The lawsuit, which is related to Datasci,s U.S. ... clinical trial data. Under the,terms of the settlement ... with Datasci on a going-forward basis., "We ...
    ... new, high-tech identification system,developed in Japan will improve ... identify victims of mass disasters, according to a ... Radiological Society of North,America (RSNA)., "Families waiting ... waiting for the identification process to resolve," said ...
    ... Contain Costs, NEW YORK, Nov. 27 ... contract with the Michigan Department of Community,Health (MDCH) ... been,extended through October 31, 2008. The contract scope ... HMS also,provides medical support enforcement services for the ...
    Cached Medicine News:
    Adsons bayonet forceps....
    Rees bayonet forceps, standard, 5-1/2", TC....
    Medpor Encophthalmos Wedge mimics the contour of the orbital floor and provides volume to restore the orbit to its normal shape and size....
    ... Implants, designed to accept rigid ... with an excellent reconstructive option ... floor blowout defects. Each design ... of one or more rigid ...
    Medicine Products: